- Trump urges swift passage of his "big, beautiful bill," warning the country will "suffer greatly" without it.
- House Republicans race against Memorial Day deadline amid internal disputes over SALT deductions and entitlement cuts.
- Senate prospects remain uncertain as Democrats prepare to oppose key provisions.
Legislative Showdown Intensifies
President Donald Trump has intensified pressure on Congress to pass his signature legislative package, framing it as critical to the nation's economic future. "The country will suffer greatly without this legislation," Trump declared, referring to the bill that would make permanent his 2017 tax cuts while implementing sweeping changes to Medicare and Medicaid.
House Republicans are working against a self-imposed Memorial Day deadline to finalize the bill, though significant divisions remain. Key sticking points include proposed limits on state and local tax (SALT) deductions—a major concern for GOP lawmakers from high-tax states—and potential cuts to entitlement programs that have drawn sharp criticism from Democrats.
Economic and Political Fault Lines
The legislation's centerpiece—permanent extension of the 2017 tax cuts—has reignited debates about fiscal responsibility. While proponents argue it would stimulate investment, critics warn of ballooning deficits. Meanwhile, proposed Medicare and Medicaid changes have become particularly contentious. Republican leaders insist savings would come from reducing waste, but opponents claim vulnerable populations would bear the brunt.
"This is about growth versus gridlock," said one House Republican aide familiar with negotiations, speaking on condition of anonymity. The aide acknowledged ongoing "robust discussions" about SALT provisions but expressed confidence the bill would clear the House.
Uncertain Path Forward
Even if the bill passes the House, its Senate prospects remain cloudy. Democrats have uniformly opposed the entitlement cuts, and some Republicans appear wary of the political risks. The White House has not commented on potential compromises, though Trump has repeatedly emphasized urgency, tying the bill's passage to his broader policy agenda.
The legislative push coincides with a flurry of recent executive actions on issues ranging from immigration to drug pricing, as the administration seeks to accelerate its agenda. Market reaction has been muted so far, with investors apparently awaiting clearer signals about the bill's fate.
Editor's Note: This article has been updated to clarify the status of Senate negotiations.